Results 151 to 160 of about 151,776 (275)

Gut microbial alterations associated with the exacerbation of experimental autoimmune uveitis in PGRN-deficient mice

open access: yesFrontiers in Immunology
PurposeProgranulin (PGRN) has been shown to play a protective role in the development of a variety of immune-mediated diseases, and the gut microbiome has been implicated in the pathogenesis of autoimmune diseases.
Wenjun Zhou, Song Zhang, Chaokui Wang
doaj   +1 more source

Eau

open access: yesRevue Juridique de l'Environnement, 2006
Sironneau Jacques. Eau. In: Revue Juridique de l'Environnement, n°3, 2006. pp. 323-336.
openaire   +2 more sources

[18F]fluorodeoxyglucose PET/CT refines staging and treatment selection in high‐risk upper tract urothelial carcinoma

open access: yesBJU International, EarlyView.
Objectives To evaluate the incremental clinical value of [18F]fluorodeoxyglucose positron emission tomography/computed tomography ([18F]FDG‐PET/CT) beyond contrast‐enhanced computed tomography (CECT) for primary staging of suspected high‐risk upper tract urothelial carcinoma (UTUC).
Renee A. G. Lijnen   +8 more
wiley   +1 more source

L’eau comme facteur des relations internationales: cas du fleuve Congo [PDF]

open access: yesMouvements et Enjeux Sociaux
L’eau douce s’impose aujourd’hui comme une ressource stratégique majeure dans les relations internationales contemporaines. Au-delà de sa fonction vitale, elle constitue un enjeu géopolitique, économique et sécuritaire croissant, particulièrement dans ...
Frédéric KABUNDI TSHIBANGU   +1 more
doaj  

Autoimmune uveitis attenuated in diabetic mice through imbalance of Th1/Th17 differentiation via suppression of AP-1 signaling pathway in Th cells

open access: yesFrontiers in Immunology
PurposeInflammation is involved in the pathogenesis of diabetes, however the impact of diabetes on organ-specific autoimmune diseases remains unexplored.
Masaru Takeuchi   +6 more
doaj   +1 more source

Surgical waiting times in patients with high‐ and low‐risk renal cell carcinoma in England

open access: yesBJU International, EarlyView.
Objectives To assess to what extent hospitals meet the uniform English National Health Service ‘timely’ treatment standard, what happens after a breach, and determinants of delay for patients with high‐risk renal cell carcinoma (RCC). Patient and Methods Population‐based study using linked data for 7030 patients with high‐risk and 10 708 patients with ...
Raghav Varma   +13 more
wiley   +1 more source

Beyond the label ‘high‐grade’: histological heterogeneity as a prognostic marker in Ta non‐muscle‐invasive bladder cancer

open access: yesBJU International, EarlyView.
Objective To evaluate whether the proportion of a high‐grade (HG) component within primary non‐muscle‐invasive bladder cancer (NMIBC) influences recurrence and progression outcomes beyond the current World Health Organization (WHO) recommended threshold of ≥5% to designate a tumour as HG.
Francis Simard   +12 more
wiley   +1 more source

sj-pdf-1-eau-10.1177_09562478241230813 – Supplemental material for The case for a climate bonus: waste pickers’ perceptions of climate change in Minas Gerais

open access: yes
Supplemental material, sj-pdf-1-eau-10.1177_09562478241230813 for The case for a climate bonus: waste pickers’ perceptions of climate change in Minas Gerais by Sonia Maria Dias, Vanesa Castán Broto, Breno Cypriano, Ana Carolina Ogando and Juliana ...
Sonia Maria Dias (18360412)   +4 more
core   +1 more source

The impact of programmed death ligand 1 expression on prognosis in penile cancer: a systematic review and meta‐analysis

open access: yesBJU International, EarlyView.
Objectives To determine the prevalence of programmed death ligand 1 (PD‐L1) expression in penile squamous cell carcinoma (PSCC) and evaluate its associations with clinicopathological features and survival outcomes. Patients and Methods A systematic review was carried out using PubMed, the Excerpta Medica dataBASE (EMBASE), Scopus, Web of Science and ...
Diarmuid D. Sugrue   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy